Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,356,029
-
Share change
-
-8,049,381
-
Total reported value
-
$1,080,455
-
Price per share
-
$0.20
-
Number of holders
-
16
-
Value change
-
-$6,821,908
-
Number of buys
-
2
-
Number of sells
-
34
Institutional Holders of SIENNA BIOPHARMACEUTICALS IN - COM (SNNAQ) as of Q3 2019
As of 30 Sep 2019,
SIENNA BIOPHARMACEUTICALS IN - COM (SNNAQ) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,356,029 shares.
The largest 10 holders included
FMR LLC, Golden State Wealth Management, LLC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., CITADEL ADVISORS LLC, TWO SIGMA INVESTMENTS, LP, UBS Group AG, GOLDMAN SACHS GROUP INC, BANK OF AMERICA CORP /DE/, and RAYMOND JAMES & ASSOCIATES.
This page lists
16
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.